Re: Efficacy and Safety of Vildagliptin and Remogliflozin as Add-on Therapy to Metformin in Patients of Type 2 Diabetes Mellitus.
Autor: | Raza H; Islamic International Medical College, Riphah International University, Rawalpindi, Pakistan., Bhutta ME; Islamic International Medical College, Riphah International University, Rawalpindi, Pakistan., Siddique MH; Islamic International Medical College, Riphah International University, Rawalpindi, Pakistan. |
---|---|
Jazyk: | angličtina |
Zdroj: | Sultan Qaboos University medical journal [Sultan Qaboos Univ Med J] 2024 Aug; Vol. 24 (3), pp. 418-419. Date of Electronic Publication: 2024 Aug 29. |
DOI: | 10.18295/squmj.8.2024.050 |
Databáze: | MEDLINE |
Externí odkaz: |